Related Experiment Video
Updated: Apr 21, 2026

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
Published on: January 19, 2024
Liver function disorders in pregnancy: physiology or pathology?
Wiktoria Sielwanowska-Lasek1, Agnieszka Mądro2
1Doctoral School, Medical University of Lublin, Lublin, Poland.
Abstract:
The occurrence of abnormal liver function markers in pregnancy does not always indicate pathology. Many biochemical changes, such as increased alkaline phosphatase at the end of pregnancy or decreased albumin and bilirubin, are physiological and do not cause concern for the health of the pregnant woman and child. However, due to their similarity to the symptoms of liver diseases, their interpretation is a diagnostic challenge. It is important to take into account the characteristic clinical course of individual diseases and the stage of pregnancy in which they most often occur. This article discusses liver diseases specific to pregnancy, such as hyperemesis gravidarum, HELLP syndrome, preeclampsia and eclampsia, intrahepatic cholestasis of pregnancy, and acute fatty liver disease of pregnancy, as well as diseases independent of it, such as autoimmune hepatitis (AIH), primary biliary cirrhosis, and primary sclerosing cholangitis. Although symptoms of some diseases may improve during pregnancy, there is a risk of exacerbations in AIH, especially in the perinatal period, which requires close monitoring and adjustment of immunosuppressive therapy. Differential diagnosis should also include drug-induced liver injury and viral infections. A thorough medical history and analysis of symptoms are important. Early diagnosis and rapid therapeutic action in the discussed diseases are crucial to minimise the risk of complications.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Cirrhosis I: Introduction

